Shen, K.R., Meyers, B.F., Larner, J.M. and Jones, D.R. (2007) American College of Chest P. Special Treatment Issues in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest, 132, 290S-305S.
https://doi.org/10.1378/chest.07-1382

has been cited by the following article:

• TITLE: Metachronous, Ipsilateral Primary Lung Cancer: A Case Report

  AUTHORS: Joseph L. Blidgen, Patrice A. Pinkney

  KEYWORDS: Lung Cancer, Adenocarcinoma, Metachronous, Jamaica

  JOURNAL NAME: Journal of Cancer Therapy, Vol.12 No.1, January 25, 2021

  ABSTRACT: Lung cancer is the most common malignant tumor in men worldwide. It has been documented that patients can develop multiple primary lung cancer, with a 5% annual risk of a second primary (metachronous) cancer occurring after prior curative treatment. Moreover, there has been an increase in the incidence of metachronous primary lung cancer reflecting a longer survival after curative resection of the primary cancer and improvements in patient surveillance methods. Herein, we present a case of a patient diagnosed with a metachronous primary lung cancer presenting 1 year after treatment of a primary lung cancer at National Chest Hospital, Kingston, Jamaica. Through strict adherence to surveillance guidelines, this metachronous cancer was detected, enabling the patient to be promptly treated.